Conor Stewart
Research expert covering health & pharmaceuticals in the UK & Europe
Get in touch with us now| Characteristic | Share of children |
|---|---|
| 2003-04 | 93.6% |
| 2004-05 | 93.3% |
| 2005-06 | 93.8% |
| 2006-07 | 93.3% |
| 2007-08 | 92.6% |
| 2008-09 | 92.5% |
| 2009-10 | 94% |
| 2010-11 | 94.7% |
| 2011-12 | 95.4% |
| 2012-13 | 95.8% |
| 2013-14 | 95.6% |
| 2014-15 | 95.6% |
| 2015-16 | 95.6% |
| 2016-17 | 95.6% |
| 2017-18 | 95.6% |
| 2018-19 | 95% |
| 2019-20 | 95.2% |
| 2020-21 | 95.2% |
| 2021-22 | 94.4% |
| 2022-23 | 93.2% |
| 2023-24* | 92.6% |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Loading statistic...
Download
Source
Sources
Release date
September 2024
More information
Region
United Kingdom (England)
Survey time period
2003/04 to 2023/24
Age group
5 years and under
Supplementary notes
Primary immunization received
*The DTaP/IPV/Hib (5-in-1) vaccine was replaced by the DTaP/IPV/Hib/HepB (6-in-1) vaccine in August 2017. Therefore, the 5-year age cohort in 2023-24 (born in 2018-19), will be the first cohort to have all received the 6-in-1 vaccination. See Appendix G in the source for full details.
Citation formats
